HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM:HCM, HKEX:13) today announces that its subsidiary, HUTCHMED Limited, has entered into an exclusive license agreement with a subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502, NYSE:TAK) to further the global development, commercialization and manufacture of fruquintinib outside of mainland China, Hong Kong and Macau, where it is market
Pliant Therapeutics, Inc. (NASDAQ: PLRX) today announced 12-week interim data from the 320 mg dose group of INTEGRIS-IPF, a multinational, randomized, double-blind, placebo-controlled Phase 2a clinical trial of bexotegrast (PLN-74809) in patients with idiopathic pulmonary fibrosis (IPF).
nternational Paper (NYSE: IP) today announced formal plans to invest approximately $103 million to build and operate two natural gas power boilers to generate steam for its Containerboard Mill in Cedar Rapids, Iowa. Construction is set to begin in the second quarter of this year and be fully operational by the end of 2025.
Alta Fox Capital Management, LLC today released the below letter sent to Daktronics, Inc. (NASDAQ: DAKT).
***
January 19, 2023
Daktronics, Inc.
Attn: The Independent Members of the Board of Directors
201 Daktronics Drive
Brookings, South Dakota 57006